Linda M. Tharby - Mar 4, 2022 Form 4 Insider Report for REPRO MED SYSTEMS INC (KRMD)

Role
President and CEO
Signature
/s/ Karen Fisher, Attorney-in-Fact
Stock symbol
KRMD
Transactions as of
Mar 4, 2022
Transactions value $
$60,924
Form type
4
Date filed
4/13/2022, 11:48 AM
Next filing
May 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRMD Common Stock Award $95.3K +31.4K +3.14% $3.03 1.03M Mar 4, 2022 Direct F1, F2
transaction KRMD Common Stock Tax liability -$34.3K -11.3K -1.1% $3.03 1.02M Mar 4, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock issued as a portion of the 2021 bonus paid in equity.
F2 Includes 150,000 in restricted stock awards that vest in 25% increments annually on 4/12/23, 4/12/24 and 4/12/25; 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.
F3 Represents shares of common stock withheld by the issuer in satisfaction of tax withholding obligations upon the issuance of common stock for the portion of the 2021 bonus paid in equity.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.